Dakshidin Corporatio

PINK:DKSC USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.77 Million
Market Cap Rank
#50900 Global
#15620 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.01
About

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its n… Read more

Dakshidin Corporatio (DKSC) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2023: -0.038x

Based on the latest financial reports, Dakshidin Corporatio (DKSC) has a cash flow conversion efficiency ratio of -0.038x as of December 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-261.00) by net assets ($6.79K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Dakshidin Corporatio - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Dakshidin Corporatio's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Dakshidin Corporatio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dakshidin Corporatio ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Dakshidin Corporatio (2019–2024)

The table below shows the annual cash flow conversion efficiency of Dakshidin Corporatio from 2019 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-03-31 $6.79K $-5.70K -0.838x 0.00%
2023-12-31 $6.79K $-5.70K -0.838x -167.64%
2023-03-31 $24.51K $30.38K 1.239x 0.00%
2022-12-31 $24.51K $30.38K 1.239x +167.79%
2022-03-31 $191.61K $-350.25K -1.828x 0.00%
2021-12-31 $191.61K $-350.25K -1.828x -1350.91%
2021-03-31 $141.78K $20.72K 0.146x 0.00%
2020-12-31 $141.78K $20.72K 0.146x -94.03%
2019-12-31 $23.53K $57.63K 2.449x --